Clinical Trial Update: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating longitudinal endotyping of atopic dermatitis through transcriptomic analysis of skin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED